{"entity":{"type":"insider","cik":"0001716821","url":"/insider/0001716821","json_url":"/insider/0001716821.json","name":"Morl Christopher John","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":14,"n_filings":6,"first":"2019-12-05","last":"2020-01-17","span_basis":"filed_date"},"name_variants":[{"name":"Morl Christopher John","source":"filing","n_filings":6,"first_seen":"2019-12-05","last_seen":"2020-01-17"}],"transactions":[{"id":2432978,"accession":"0001209191-20-003949","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-003949","line_url":"/filing/0001209191-20-003949#line-4","is_derivative":false,"issuer_cik":"0001654151","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001654151","owner_cik":"0001716821","owner_name":"Morl Christopher John","owner_display_name":"Morl Christopher John","owner_url":"/insider/0001716821","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3011.0,"shares_display":"3,011","price_per_share":65.4041,"price_display":"65.40","price_state":"stated","total_value":196931.7451,"total_display":"196,931.75","total_whole":"196,932","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-16","filed_date":"2020-01-17","scope":"insider"},{"id":2432973,"accession":"0001209191-20-003949","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-003949","line_url":"/filing/0001209191-20-003949#line-2","is_derivative":false,"issuer_cik":"0001654151","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001654151","owner_cik":"0001716821","owner_name":"Morl Christopher John","owner_display_name":"Morl Christopher John","owner_url":"/insider/0001716821","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12023.0,"shares_display":"12,023","price_per_share":65.2311,"price_display":"65.23","price_state":"stated","total_value":784273.5153,"total_display":"784,273.52","total_whole":"784,274","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-15","filed_date":"2020-01-17","scope":"insider"},{"id":3253243,"accession":"0001209191-20-002708","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-002708","line_url":"/filing/0001209191-20-002708#line-4","is_derivative":false,"issuer_cik":"0001654151","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001654151","owner_cik":"0001716821","owner_name":"Morl Christopher John","owner_display_name":"Morl Christopher John","owner_url":"/insider/0001716821","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12281.0,"shares_display":"12,281","price_per_share":60.115,"price_display":"60.12","price_state":"stated","total_value":738272.315,"total_display":"738,272.32","total_whole":"738,272","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-08","filed_date":"2020-01-09","scope":"insider"},{"id":3253232,"accession":"0001209191-20-002708","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-002708","line_url":"/filing/0001209191-20-002708#line-2","is_derivative":false,"issuer_cik":"0001654151","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001654151","owner_cik":"0001716821","owner_name":"Morl Christopher John","owner_display_name":"Morl Christopher John","owner_url":"/insider/0001716821","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1650.0,"shares_display":"1,650","price_per_share":60.0215,"price_display":"60.02","price_state":"stated","total_value":99035.475,"total_display":"99,035.48","total_whole":"99,035","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-07","filed_date":"2020-01-09","scope":"insider"},{"id":2282851,"accession":"0001209191-20-001759","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-20-001759","line_url":"/filing/0001209191-20-001759","is_derivative":false,"issuer_cik":"0001654151","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001654151","owner_cik":"0001716821","owner_name":"Morl Christopher John","owner_display_name":"Morl Christopher John","owner_url":"/insider/0001716821","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16137.0,"shares_display":"16,137","price_per_share":58.55314290760364,"price_display":"58.55","price_state":"stated","total_value":944872.0671,"total_display":"944,872.07","total_whole":"944,872","shares_owned_after":7632.0,"shares_owned_after_display":"7,632","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-02","filed_date":"2020-01-06","scope":"insider","n_lines":6},{"id":8011463,"accession":"0001209191-19-060446","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-060446","line_url":"/filing/0001209191-19-060446#line-2","is_derivative":false,"issuer_cik":"0001654151","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001654151","owner_cik":"0001716821","owner_name":"Morl Christopher John","owner_display_name":"Morl Christopher John","owner_url":"/insider/0001716821","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15034.0,"shares_display":"15,034","price_per_share":60.0,"price_display":"60.00","price_state":"stated","total_value":902040.0,"total_display":"902,040.00","total_whole":"902,040","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-12","filed_date":"2019-12-13","scope":"insider"},{"id":8300687,"accession":"0001209191-19-060041","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-060041","line_url":"/filing/0001209191-19-060041#line-4","is_derivative":false,"issuer_cik":"0001654151","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001654151","owner_cik":"0001716821","owner_name":"Morl Christopher John","owner_display_name":"Morl Christopher John","owner_url":"/insider/0001716821","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11647.0,"shares_display":"11,647","price_per_share":55.0,"price_display":"55.00","price_state":"stated","total_value":640585.0,"total_display":"640,585.00","total_whole":"640,585","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-10","filed_date":"2019-12-11","scope":"insider"},{"id":8300679,"accession":"0001209191-19-060041","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-060041","line_url":"/filing/0001209191-19-060041#line-2","is_derivative":false,"issuer_cik":"0001654151","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001654151","owner_cik":"0001716821","owner_name":"Morl Christopher John","owner_display_name":"Morl Christopher John","owner_url":"/insider/0001716821","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3387.0,"shares_display":"3,387","price_per_share":55.0,"price_display":"55.00","price_state":"stated","total_value":186285.0,"total_display":"186,285.00","total_whole":"186,285","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-09","filed_date":"2019-12-11","scope":"insider"},{"id":8601728,"accession":"0001209191-19-059293","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-059293","line_url":"/filing/0001209191-19-059293#line-2","is_derivative":false,"issuer_cik":"0001654151","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001654151","owner_cik":"0001716821","owner_name":"Morl Christopher John","owner_display_name":"Morl Christopher John","owner_url":"/insider/0001716821","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15034.0,"shares_display":"15,034","price_per_share":50.0042,"price_display":"50.00","price_state":"stated","total_value":751763.1428,"total_display":"751,763.14","total_whole":"751,763","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-03","filed_date":"2019-12-05","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":14,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":14,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":14},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001654151","name":"Deciphera Pharmaceuticals, Inc.","url":"/issuer/0001654151","role":"Officer (Chief Business Officer)","n_filings":6,"first_seen":"2019-12-05","last_seen":"2020-01-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001716821","retrieved_at":"2026-08-25T21:08:40+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}